-
Katie Price recalls sad experience related to differently abled son Harvey
Published: 2 days ago | (Link to Geo.tv)
Katie Price shared an anecdote about her life son Harvey, who suffers from Prader-Willi syndrome.
-
Soleno’s VYKAT XR To Treat Hyperphagia In Patients With Prader-Willi Syndrome Now Available In U.S
Published: 6 days ago | (Link to RTTNews)
Soleno Therapeutics, Inc. (SLNO), Monday said VYKAT XR which was approved by the Food and Drug Administration (FDA) on March 26 to treat hyperphagia in…
-
Soleno launches Vykat xr for hyperphagia in Prader-Willi syndrome (SLNO:NASDAQ)
Published: 6 days ago | (Link to Seeking Alpha)
Vykat xr is now commercially available for treating hyperphagia in Prader-Willi syndrome. Read more here.
-
Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved
Published: 6 days ago | (Link to MSN)
Shares of biopharmaceutical company Soleno Therapeutics, Inc. (SLNO) were in the spotlight on Monday after the company announced the launch of its VYKAT XR…
-
Raising a child with Prader-Willi Syndrome
Published: 6 days ago | (Link to Free Malaysia Today)
Azman Ahmad Bakri and Farahiah Ariffin hope to shed light on this rare condition, which causes those affected to constantly feel hungry and never satiated.
-
Breakthrough PWS Treatment VYKAT XR Now Available: First-Ever FDA Approval for Rare Disease
Published: 6 days ago | (Link to Stock Titan)
First prescriptions delivered for novel PWS hyperphagia treatment. Soleno ONE support program launches to ensure patient access. See launch details inside.
-
Soleno Therapeutics Announces VYKAT(TM) XR Launch
Published: 6 days ago | (Link to GlobeNewswire)
REDWOOD CITY, Calif., April 14, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel…
-
Soleno Therapeutics launches FDA-approved PWS treatment By Investing.com
Published: 6 days ago | (Link to Investing.com South Africa)
REDWOOD CITY, Calif. – Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company with a market capitalization of $3.08 billion, announced today…
